T/CMBA 013-2021 Active Group standards

T/CMBA 013-2021 The standard for clinical application of managing antigen-presenting cells and T cell therapy products in medical institutions

Publish Date: 2021-02-01 Implement Date: 2021-02-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/CMBA 013-2021

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: -

ICS Name: Integrated medical science and healthcare devices

Publish Date: 2021-02-01

Implement Date: 2021-02-01

Scope

Main technical content: This document stipulates the requirements for medical institutions using CAR-T cell therapy products in terms of facilities and equipment, personnel, systems and procedures, quality management, treatment, records, and labeling

Development Information

Related Standards

GB 3232-1982 Abolished

GB 3232-1982 Diagnostic criteria and principles of management of occupational chronic manganism

Publish Date: 1982-10-25

GB 3233-1982 Abolished

GB 3233-1982 Diagnostic criteria and principles of management of occupational chronic carbon disulfide poisoning

Publish Date: 1982-10-25

GB 3234-1982 Abolished

GB 3234-1982 Diagnostic criteria and principles of management of industrial fluorosis

Publish Date: 1982-10-25

GB 4865-1985 Abolished

GB 4865-1985 Diagnostic criteria and principles of management of occupational chronic allyl chloride poisoning

Publish Date: 1985-01-14

GB 4869-1985 Abolished

GB 4869-1985 Diagnostic criteria and principles of management of occupational vibration disease

Publish Date: 1985-01-14

GB 5044-1985 Abolished

GB 5044-1985 Classification of health hazard levels from occupational exposure to toxic substances

Publish Date: 1985-04-02